Dr Pegram discusses treatment sequencing in metastatic HER2-positive breast cancer, recent updates to the National Comprehensive Cancer Network guidelines, and the influence of the DESTINY-Breast03 trial on the breast cancer treatment paradigm.

S6 Ep46: Pegram Expounds on Exciting Developments in HER2+ Metastatic Breast Cancer

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

Share S6 Ep46: Pegram Expounds on Exciting Developments in HER2+ Metastatic Breast Cancer

Sign up to save your podcasts

S6 Ep46: Pegram Expounds on Exciting Developments in HER2+ Metastatic Breast Cancer

S6 Ep46: Pegram Expounds on Exciting Developments in HER2+ Metastatic Breast Cancer

More shows like OncLive® On Air

Hematologic Oncology Update

NEJM This Week

Journal of Clinical Oncology (JCO) Podcast

Research To Practice | Oncology Videos

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

JAMA Clinical Reviews

ASCO Daily News

The Curbsiders Internal Medicine Podcast

OncoPharm

ASCO Guidelines

Lung Cancer Considered

Oncology Today with Dr Neil Love

Two Onc Docs

JCO Precision Oncology Conversations

Oncology Brothers: Practice-Changing Cancer Discussions